Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew, Lovise Maehle, Karol Axcrona, D Gareth Evans, Barbara Bulman, Diana Eccles, Donna McBride, Christi van Asperen, Hans Vasen, Lambertus A Kiemeney, Janneke Ringelberg Show all
European Urology | ELSEVIER | Published : 2014
Awarded by Cancer Research UK
Awarded by National Institute for Health Research
Awarded by Worldwide Cancer Research
Rosalind A. Eeles certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Hans Lilja holds patents for free PSA, hK2, and intact PSA assays. Rosalind A. Eeles has received educational grants from Janssen Pharmaceuticals, GenProbe (formerly Tepnel), Illumina, and Vista Diagnostics and honoraria from Succinct Communications.